Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
5-Amino-1MQ is an orally bioavailable, cell-permeable small molecule that potently inhibits NNMT (nicotinamide N-methyltransferase), the enzyme responsible for methylating nicotinamide to 1-methylnicotinamide (1-MNA)
IV administration is fast and effective for: Quickly fixing severe deficiencies
Excipients in formulations may occasionally trigger sensitivity reactions in some individuals
Dosing typically begins at a lower dose, suggested initiation of 20 units (0.2 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 14: Inject 20 units (0.2 mL) one time per week Weeks 58: Inject 40 units (0.4 mL) one time per week Weeks 912: Inject 70 units (0.7 mL) one time per week Weeks 1316: Inject 90 units (0.9 mL) one time per week Weeks 1720: Inject 120 units (1.2 mL) one time per week Week 21+: Inject 140 units (1.4 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs
Method of Use: Dosage and duration of treatment should be supervised by a healthcare professional, adapting to the severity of each case (e.g., diabetic neuropathy or sciatica)
US$ 20.55
US$ 28.33
US$ 22.01
US$ 26.87
US$ 23.84
US$ 20.97
US$ 28.08
US$ 23.09
US$ 21.90
US$ 28.26
US$ 25.82
